Renaissance Technologies LLC Takes $720,000 Position in Senseonics Holdings, Inc. (NYSE:SENS)

Renaissance Technologies LLC acquired a new stake in Senseonics Holdings, Inc. (NYSE:SENS - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,376,020 shares of the company's stock, valued at approximately $720,000. Renaissance Technologies LLC owned about 0.23% of Senseonics at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the business. Raymond James Financial Inc. acquired a new position in shares of Senseonics in the 4th quarter valued at $26,000. HighTower Advisors LLC purchased a new stake in shares of Senseonics during the 4th quarter worth about $32,000. Ridgecrest Wealth Partners LLC acquired a new stake in shares of Senseonics in the fourth quarter worth $60,000. Geode Capital Management LLC raised its position in Senseonics by 3.2% in the third quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company's stock valued at $2,042,000 after purchasing an additional 179,103 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in Senseonics by 9.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,339,698 shares of the company's stock worth $1,748,000 after acquiring an additional 274,842 shares in the last quarter. 12.36% of the stock is currently owned by hedge funds and other institutional investors.

Senseonics Stock Performance

Shares of SENS stock traded down $0.01 during trading hours on Friday, reaching $0.71. The stock had a trading volume of 4,243,242 shares, compared to its average volume of 6,341,502. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38. The firm has a 50-day simple moving average of $0.67 and a 200-day simple moving average of $0.62. The firm has a market capitalization of $464.49 million, a PE ratio of -5.46 and a beta of 1.05. Senseonics Holdings, Inc. has a twelve month low of $0.25 and a twelve month high of $1.40.

Senseonics (NYSE:SENS - Get Free Report) last posted its earnings results on Monday, March 3rd. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.09). Senseonics had a negative net margin of 362.30% and a negative return on equity of 842.25%. During the same period last year, the firm earned ($0.07) earnings per share. As a group, equities analysts forecast that Senseonics Holdings, Inc. will post -0.14 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. HC Wainwright reissued a "buy" rating and issued a $2.00 price target on shares of Senseonics in a report on Wednesday, March 5th. Mizuho started coverage on shares of Senseonics in a research note on Thursday, April 10th. They issued an "outperform" rating and a $2.00 price target for the company.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.